FERNANDO PEREZ-MAGNELLI: Open Payments
NPI 1649276999 · WENTZVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,154 in 65 payments from 17 companies in 2025. Trend: 2023 $768 · 2024 $389 · 2025 $1,154
Food & beverage: $1,154
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 13 | $207 |
| Otsuka America Pharmaceutical, Inc. | 8 | $143 |
| Supernus Pharmaceuticals, Inc. | 6 | $111 |
| Vanda Pharmaceuticals Inc. | 5 | $104 |
| Collegium Pharmaceutical, Inc. | 5 | $102 |
| Janssen Pharmaceuticals, Inc | 4 | $96 |
| Corium, LLC | 7 | $83 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
Products named: ARISTADA, REXULTI, Qelbree, FANAPT, Jornay PM, Azstarys, SPRAVATO, Auvelity.
Industry payments across MO — which companies pay providers there.
